Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue

Alcohol. 2019 Sep:79:71-79. doi: 10.1016/j.alcohol.2018.12.005. Epub 2019 Jan 3.

Abstract

Background: We previously reported that nanoformulated copper/zinc superoxide dismutase (Nano) attenuates non-alcoholic fatty liver disease and adipose tissue (AT) inflammation in obese animals. Here, we sought to determine whether Nano treatment attenuates alcohol-associated liver disease (AALD) and AT inflammation in alcohol-fed mice.

Methods: We pre-treated E-47 cells (HepG2 cells that over-express CYP2E1) with native- or nano-superoxide dismutase (SOD) for 6 h, followed by treatment with ethanol and/or linoleic acid (LA), a free fatty acid. For in vivo studies, male C57BL/6 mice were fed the Lieber-DeCarli control or ethanol liquid diet for 4 weeks. The mice received Nano once every 2 days during the last 2 weeks of ethanol feeding.

Results: Our in vitro studies revealed that Nano pretreatment reduced LA + ethanol-induced oxidative stress in E-47 cells. Our in vivo experiments showed that ethanol-fed Nano-treated mice had 22% lower hepatic triglyceride levels than mice fed ethanol alone. Nano-treated ethanol-fed mice also had 2-fold lower levels of Cd68 and similarly reduced levels of Ccl2 and Mmp12 mRNAs, than in untreated ethanol-fed mice. We also noted that ethanol feeding caused a remarkable increase in hepatic and/or plasma MCP-1 and CCR2 protein, which was blunted in ethanol + Nano-treated animals. The hepatic content of SREBP-1c, a transcription factor that promotes lipogenesis, was higher in ethanol-fed mice than controls but was attenuated in ethanol + Nano-treated animals. Further, livers of ethanol + Nano-treated mice had significantly higher levels of phosphorylated adenosine monophosphate-activated protein kinase (AMPK) than both control and ethanol-fed mice. In AT, the levels of Il6 mRNA, a hepatoprotective cytokine, and that of Arg1, a marker of anti-inflammatory macrophages, were significantly increased in ethanol + Nano-treated mice compared with control mice.

Conclusion: Our data indicate that Nano treatment attenuates ethanol-induced steatohepatitis and that this effect is associated with an apparent activation of AMPK signaling. Our data also suggest that Nano induces Arg1 and Il6 expression in AT, suggesting anti-inflammatory effects in this tissue.

Keywords: AMPK; Ethanol; MCP1; SOD1; Steatohepatitis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Adipose Tissue / drug effects*
  • Animals
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Chemokine CCL2 / metabolism
  • Cytochrome P-450 CYP2E1 / genetics
  • Drug Compounding
  • Ethanol / adverse effects*
  • Free Radical Scavengers / pharmacology*
  • Gene Expression
  • Hep G2 Cells
  • Humans
  • Inflammation / enzymology*
  • Lipid Metabolism
  • Liver / drug effects*
  • Liver Diseases, Alcoholic / enzymology*
  • Male
  • Matrix Metalloproteinase 12 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Nanostructures
  • Oxidative Stress
  • Protein Kinases / metabolism
  • Receptors, CCR2 / metabolism
  • Sterol Regulatory Element Binding Protein 1 / metabolism
  • Superoxide Dismutase / pharmacology*

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 protein, mouse
  • Ccl2 protein, mouse
  • Ccr2 protein, mouse
  • Chemokine CCL2
  • Free Radical Scavengers
  • Receptors, CCR2
  • Sterol Regulatory Element Binding Protein 1
  • Ethanol
  • Cytochrome P-450 CYP2E1
  • Superoxide Dismutase
  • Protein Kinases
  • AMP-Activated Protein Kinase Kinases
  • Matrix Metalloproteinase 12
  • matrix metallopeptidase 12, mouse